Journals
Publish with us
Publishing partnerships
About us
Blog
Disease Markers
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Disease Markers
/
2022
/
Article
/
Tab 3
/
Research Article
[Retracted] Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function
Table 3
Comparison of vascular endothelial function.
Indices
Control group (
)
Dapagliflozin group (
)
value
value
RHI value (
)
Upon admission
7.232
0.475
After 20 weeks of treatment
9.023
0.023
(
,
%)
Upon admission
13 (42.96)
12 (39.98)
11.378
0.798
After 20 weeks of treatment
12 (39.98)
5 (15.88)
11.208
0.044